Phase 3 Malaria, Vivax Trials
2 Phase 3 trials for Malaria, Vivax. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.
What is a Phase 3 trial?
Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.
RECRUITINGPhase 3NCT06923592
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages (hypnozoites) that reactivate weeks to months after the initial...
Sponsor: London School of Hygiene and Tropical MedicineEnrolling: 192002 locations
RECRUITINGPhase 3NCT06666491
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are...
The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.
Sponsor: GlaxoSmithKlineEnrolling: 3004 locations